Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately distinguishes harmful gene variations from harmless ones, potentially enhancing physicians’ ability to diagnose diseases. The new tool could pave the way for more precise personalized medicine and targeted therapies.